Note 17 - Condensed Consolidating Financial Information of Guarantor Subsidiaries (Tables)

3 Months Ended

Aug. 31, 2015

Disclosure Text Block Supplement [Abstract]

Condensed Balance Sheet [Table Text Block]

	Immucor, Inc.		Guarantors			Non-Guarantors		Eliminations			Total
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	6,503		(449	)		12,973		-			19,027
Accounts receivable, net		28,704		5,888			31,091		-			65,683
Intercompany receivable		74,871		18,891			7,902		(101,664	)		-
Inventories, net		21,748		15,132			13,466		(1,893	)		48,453
Deferred income tax assets, current portion		2,511		2,254			481		731			5,977
Prepaid expenses and other current assets		4,763		470			4,922		-			10,155
Total current assets		139,100		42,186			70,835		(102,826	)		149,295
PROPERTY AND EQUIPMENT, net		39,309		13,428			20,603		-			73,340
INVESTMENT IN SUBSIDIARIES		219,954		5,020			3,019		(227,993	)		-
GOODWILL		744,149		47,985			50,176		-			842,310
OTHER INTANGIBLE ASSETS, net		545,147		58,250			33,549		-			636,946
DEFERRED FINANCING COSTS, net		24,645		-			-		-			24,645
OTHER ASSETS		14,711		436			375		-			15,522
Total assets	$	1,727,015		167,305			178,557		(330,819	)		1,742,058
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable	$	9,214		2,794			3,969		-			15,977
Intercompany payable		2,423		90,626			8,615		(101,664	)		-
Accrued interest and interest rate swap liability		8,177		-			-		-			8,177
Accrued expenses and other current liabilities		8,108		4,556			6,422		-			19,086
Income taxes payable		30,031		(30,090	)		3,311		-			3,252
Deferred revenue, current portion		1,691		4			1,261		-			2,956
Current portion of long term debt, net of debt discounts		20,433		4			-		-			20,437
Total current liabilities		80,077		67,894			23,578		(101,664	)		69,885
LONG TERM DEBT, net of debt discounts		1,032,334		-			-		-			1,032,334
DEFERRED INCOME TAX LIABILITIES		220,801		2,238			9,641		-			232,680
OTHER LONG-TERM LIABILITIES		16,367		12,035			1,320		-			29,722
Total liabilities		1,349,579		82,167			34,539		(101,664	)		1,364,621
SHAREHOLDERS' EQUITY:
Total shareholders' equity		377,436		85,138			144,018		(229,155	)		377,437
Total liabilities and shareholders' equity	$	1,727,015		167,305			178,557		(330,819	)		1,742,058

	Immucor, Inc.		Guarantors			Non-Guarantors		Eliminations			Total
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	7,080		(263	)		11,546		-			18,363
Accounts receivable, net		30,442		6,014			31,218		-			67,674
Intercompany receivable		68,815		24,201			8,861		(101,877	)		-
Inventories		18,361		13,706			11,830		(2,050	)		41,847
Deferred income tax assets, current portion		2,512		2,253			375		791			5,931
Prepaid expenses and other current assets		5,178		426			5,557		-			11,161
Total current assets		132,388		46,337			69,387		(103,136	)		144,976
PROPERTY AND EQUIPMENT, net		38,915		13,849			20,810		-			73,574
INVESTMENT IN SUBSIDIARIES		220,412		5,021			3,019		(228,452	)		-
GOODWILL		744,149		47,640			50,469		-			842,258
OTHER INTANGIBLE ASSETS, net		557,133		59,164			33,997		-			650,294
DEFERRED FINANCING COSTS, net		26,399		-			-		-			26,399
OTHER ASSETS		14,533		310			342		-			15,185
Total assets	$	1,733,929		172,321			178,024		(331,588	)		1,752,686
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable	$	6,297		2,604			4,965		-			13,866
Intercompany payable		2,389		91,547			7,941		(101,877	)		-
Accrued interest and interest swap liability		19,288		-			-		-			19,288
Accrued expenses and other current liabilities		13,758		5,131			7,319		-			26,208
Income taxes payable		30,061		(30,074	)		3,509		-			3,496
Deferred revenue, current portion		1,498		7			1,198		-			2,703
Current portion of long-term debt, net of debt discounts		4,462		7			-		-			4,469
Total current liabilities		77,753		69,222			24,932		(101,877	)		70,030
LONG-TERM DEBT, net of debt discounts		1,033,276		-			-		-			1,033,276
DEFERRED INCOME TAX LIABILITIES		223,232		3,639			9,616		-			236,487
OTHER LONG-TERM LIABILITIES		15,987		11,908			1,317		-			29,212
Total liabilities		1,350,248		84,769			35,865		(101,877	)		1,369,005
SHAREHOLDERS' EQUITY:
Total shareholders' equity		383,681		87,552			142,159		(229,711	)		383,681
Total liabilities and shareholders' equity	$	1,733,929		172,321			178,024		(331,588	)		1,752,686

Condensed Income Statement [Table Text Block]

	Immucor, Inc.			Guarantors			Non-Guarantors			Eliminations			Total
NET SALES	$	63,887			14,718			35,299			(17,192	)		96,712
COST OF SALES (exclusive of amortization shown separately below)		20,264			8,967			22,603			(17,192	)		34,642
GROSS PROFIT		43,623			5,751			12,696			-			62,070
OPERATING EXPENSES:
Research and development		2,639			4,019			172			-			6,830
Selling and marketing		6,401			2,545			5,041			-			13,987
Distribution		2,443			389			1,587			-			4,419
General and administrative		7,288			1,300			2,158			-			10,746
Amortization expense		11,972			1,069			537			-			13,578
Total operating expenses		30,743			9,322			9,495			-			49,560
INCOME (LOSS) FROM OPERATIONS		12,880			(3,571	)		3,201			-			12,510
NON-OPERATING (EXPENSE) INCOME:
Interest income		39			-			25			(22	)		42
Interest expense		(22,384	)		(118	)		(12	)		22			(22,492	)
Other, net		525			(128	)		(524	)		-			(127	)
Total non-operating net expense		(21,820	)		(246	)		(511	)		-			(22,577	)
(LOSS) INCOME BEFORE INCOME TAXES		(8,940	)		(3,817	)		2,690			-			(10,067	)
(BENEFIT) PROVISION FOR INCOME TAXES		(2,250	)		(1,401	)		801			-			(2,850	)
NET (LOSS) INCOME BEFORE EARNINGS OF CONSOLIDATED SUBSIDIARIES		(6,690	)		(2,416	)		1,889			-			(7,217	)
Net (loss) income of consolidated subsidiaries		(527	)		-			-			527			-
NET (LOSS) INCOME	$	(7,217	)		(2,416	)		1,889			527			(7,217	)

	Immucor, Inc.			Guarantors			Non-Guarantors			Eliminations			Total
NET SALES	$	66,268			14,614			39,573			(18,014	)		102,441
COST OF SALES (exclusive of amortization shown separately below)		20,775			9,627			24,439			(18,014	)		36,827
GROSS PROFIT		45,493			4,987			15,134			-			65,614
OPERATING EXPENSES:
Research and development		2,640			4,214			224			-			7,078
Selling and marketing		6,237			2,695			6,124			-			15,056
Distribution		2,680			388			1,972			-			5,040
General and administrative		7,261			1,045			2,578			-			10,884
Amortization expense		11,971			1,076			635			-			13,682
Total operating expenses		30,789			9,418			11,533			-			51,740
INCOME (LOSS) FROM OPERATIONS		14,704			(4,431	)		3,601			-			13,874
NON-OPERATING (EXPENSE) INCOME:
Interest income		3			-			78			(25	)		56
Interest expense		(22,180	)		(123	)		(20	)		25			(22,298	)
Other, net		143			(40	)		(27	)		-			76
Total non-operating (expense) income		(22,034	)		(163	)		31			-			(22,166	)
(LOSS) INCOME BEFORE INCOME TAXES		(7,330	)		(4,594	)		3,632			-			(8,292	)
(BENEFIT) PROVISION FOR INCOME TAXES		(2,189	)		(1,734	)		1,110			-			(2,813	)
NET (LOSS) INCOME BEFORE EARNINGS OF CONSOLIDATED SUBSIDIARIES		(5,141	)		(2,860	)		2,522			-			(5,479	)
Net (loss) income of consolidated subsidiaries		(338	)		-			-			338			-
NET (LOSS) INCOME	$	(5,479	)		(2,860	)		2,522			338			(5,479	)

Condensed Cash Flow Statement [Table Text Block]

	Immucor, Inc.			Guarantors			Non-Guarantors			Eliminations		Total
Net cash provided by (used in) operating activities	$	(9,987	)		691			1,389			-		(7,907	)
Net cash used in investing activities		(4,942	)		(873	)		(26	)		-		(5,841	)
Net cash (used in) provided by financing activities		14,342			(4	)		-			-		14,338
Effect of exchange rate changes on cash and cash equivalents		10			-			64			-		74
Increase (decrease) in cash and cash equivalents		(577	)		(186	)		1,427			-		664
Cash and cash equivalents at beginning of period		7,080			(263	)		11,546			-		18,363
Cash and cash equivalents at end of period	$	6,503			(449	)		12,973			-		19,027

	Immucor, Inc.			Guarantors			Non-Guarantors			Eliminations		Total
Net cash provided by (used in) operating activities	$	2,858			124			(3,288	)		-		(306	)
Net cash used in investing activities		(2,728	)		(369	)		(429	)		-		(3,526	)
Net cash used in financing activities		(1,659	)		(5	)		-			-		(1,664	)
Effect of exchange rate changes on cash and cash equivalents		(57	)		-			(713	)		-		(770	)
Decrease in cash and cash equivalents		(1,586	)		(250	)		(4,430	)		-		(6,266	)
Cash and cash equivalents at beginning of period		4,898			(445	)		19,168			-		23,621
Cash and cash equivalents at end of period	$	3,312			(695	)		14,738			-		17,355